Figure 5. . Pooled risk ratio for objective response rate, all-grade adverse events, and high-grade adverse events in patients with NSCLC receiving chemoimmunotherapy versus chemotherapy.

(A) Pooled RR for ORR in patients with advanced NSCLC treated with first-line chemoimmunotherapy. (B) Pooled RR for all-grade AEs in patients with advanced NSCLC treated with first-line chemoimmunotherapy. (C) Pooled RR for high-grade AEs in patients with advanced NSCLC treated with first-line chemoimmunotherapy.

AE: Adverse event; NSCLC: Non-small-cell lung cancer; ORR: Objective response rate; RR: Risk ratio.